Cosmos Health Inc. (COSM) - Net Assets

Latest as of March 2026: $18.42 Million USD

Based on the latest financial reports, Cosmos Health Inc. (COSM) has net assets worth $18.42 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($65.48 Million) and total liabilities ($47.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check COSM asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $18.42 Million
% of Total Assets 28.14%
Annual Growth Rate N/A
5-Year Change 320.71%
10-Year Change N/A
Growth Volatility 343.39

Cosmos Health Inc. - Net Assets Trend (2010–2025)

This chart illustrates how Cosmos Health Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore COSM total assets for the complete picture of this company's asset base.

Annual Net Assets for Cosmos Health Inc. (2010–2025)

The table below shows the annual net assets of Cosmos Health Inc. from 2010 to 2025. For live valuation and market cap data, see market value of Cosmos Health Inc..

Year Net Assets Change
2025-12-31 $18.42 Million -24.90%
2024-12-31 $24.53 Million -31.93%
2023-12-31 $36.04 Million -9.11%
2022-12-31 $39.66 Million +805.52%
2021-12-31 $4.38 Million +205.25%
2020-12-31 $-4.16 Million +35.60%
2019-12-31 $-6.46 Million -94.75%
2018-12-31 $-3.32 Million -9.56%
2017-12-31 $-3.03 Million -72.74%
2016-12-31 $-1.75 Million -40.47%
2015-12-31 $-1.25 Million -122.80%
2014-12-31 $5.47 Million +10296.00%
2013-12-31 $-53.68K -3838.66%
2012-12-31 $-1.36K +71.38%
2011-12-31 $-4.76K +72.76%
2010-12-31 $-17.48K --

Equity Component Analysis

This analysis shows how different components contribute to Cosmos Health Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 13316727300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $41.15K 0.22%
Other Comprehensive Income $331.50K 1.80%
Other Components $151.22 Million 820.75%
Total Equity $18.42 Million 100.00%

Cosmos Health Inc. Competitors by Market Cap

The table below lists competitors of Cosmos Health Inc. ranked by their market capitalization.

Company Market Cap
Mcphersons Ltd
AU:MCP
$13.24 Million
PT Dafam Property Indonesia Tbk
JK:DFAM
$13.25 Million
Libet S.A.
WAR:LBT
$13.25 Million
Purefun Group AB
ST:PURE
$13.26 Million
KOAS Co. Ltd
KO:071950
$13.24 Million
PT Jaya Bersama Indo Tbk
JK:DUCK
$13.23 Million
Cardiex Ltd
AU:CDX
$13.23 Million
Inbest Prime III Inmuebles SOCIMI S.A.
MC:YINB3
$13.23 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cosmos Health Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 24,532,929 to 18,424,629, a change of -6,108,300 (-24.9%).
  • Net loss of 19,144,998 reduced equity.
  • New share issuances of 5,417,396 increased equity.
  • Other comprehensive income increased equity by 2,466,434.
  • Other factors increased equity by 5,152,868.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-19.14 Million -103.91%
Share Issuances $5.42 Million +29.4%
Other Comprehensive Income $2.47 Million +13.39%
Other Changes $5.15 Million +27.97%
Total Change $- -24.90%

Book Value vs Market Value Analysis

This analysis compares Cosmos Health Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.42x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2009-12-31 $-0.06 $0.25 x
2010-12-31 $-0.21 $0.25 x
2011-12-31 $-0.05 $0.25 x
2012-12-31 $-0.01 $0.25 x
2013-12-31 $-0.13 $0.25 x
2014-12-31 $10.88 $0.25 x
2015-12-31 $-2.48 $0.25 x
2016-12-31 $-3.49 $0.25 x
2017-12-31 $-5.92 $0.25 x
2018-12-31 $-6.23 $0.25 x
2019-12-31 $-12.17 $0.25 x
2020-12-31 $-7.82 $0.25 x
2021-12-31 $6.67 $0.25 x
2022-12-31 $20.57 $0.25 x
2023-12-31 $2.27 $0.25 x
2024-12-31 $1.28 $0.25 x
2025-12-31 $0.61 $0.25 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cosmos Health Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -103.91%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -29.33%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 3.55x
  • Recent ROE (-103.91%) is below the historical average (-19.27%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2009 0.00% 0.00% 0.00x 0.00x $-4.14K
2010 0.00% 0.00% 0.00x 0.00x $-3.79 Million
2011 0.00% 0.00% 0.00x 0.00x $-168.77K
2012 0.00% 0.00% 0.00x 0.00x $-314.70
2013 0.00% 27.33% 1.04x 0.00x $251.96K
2014 110.43% 79.13% 1.06x 1.32x $5.50 Million
2015 0.00% -1252.88% 0.81x 0.00x $-6.56 Million
2016 0.00% -8.90% 2.17x 0.00x $-425.72K
2017 0.00% -20.69% 2.81x 0.00x $-5.91 Million
2018 0.00% -24.43% 1.79x 0.00x $-8.73 Million
2019 0.00% -8.31% 1.66x 0.00x $-2.65 Million
2020 0.00% 1.48% 1.26x 0.00x $1.24 Million
2021 -181.80% -14.16% 1.14x 11.29x $-8.40 Million
2022 -34.88% -27.47% 0.74x 1.72x $-17.80 Million
2023 -51.45% -34.74% 0.81x 1.83x $-22.15 Million
2024 -65.96% -29.73% 1.00x 2.21x $-18.64 Million
2025 -103.91% -29.33% 1.00x 3.55x $-20.99 Million

Industry Comparison

This section compares Cosmos Health Inc.'s net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $410,730,467
  • Average return on equity (ROE) among peers: -11.84%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Cosmos Health Inc. (COSM) $18.42 Million 0.00% 2.55x $13.24 Million
Accendra Health Inc (ACH) $565.23 Million -64.17% 7.24x $216.32 Million
Akso Health Group ADR (AHG) $12.29 Million -137.15% 3.13x $807.33 Million
Cardinal Health Inc (CAH) $1.33 Billion 13.59% 1.33x $43.01 Billion
Cencora Inc. (COR) $2.46 Billion 29.27% 5.29x $50.53 Billion
EDAP TMS SA (EDAP) $17.36 Million -6.13% 0.66x $154.80 Million
Empro Group Inc. Ordinary shares (EMPG) $1.53 Million 49.22% 2.01x $143.05 Million
Henry Schein Inc (HSIC) $867.97 Million 13.59% 0.80x $7.86 Billion
McKesson Corporation (MCK) $-1.79 Billion 0.00% 0.00x $88.33 Billion
Owens & Minor Inc (OMI) $235.30 Million -4.80% 2.65x $185.63 Million

About Cosmos Health Inc.

NASDAQ:COSM USA Medical Distribution
Market Cap
$13.24 Million
Market Cap Rank
#26329 Global
#5369 in USA
Share Price
$0.25
Change (1 day)
-0.90%
52-Week Range
$0.25 - $1.25
All Time High
$312.50
About

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more